Science Explorer Interactive view Map
Company · Espoo · Finland

Novo Nordisk (Finland)

novonordisk.fiROR OpenAlex
Research works
43
▲ 61% vs 2013–17
Citations
901
20.9 per fractional work
Top-10% rate
30.4%
record average 16.5%
Open access
73%
world 28%

Not ranked overall: Novo Nordisk (Finland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.11× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 1.84× its world share, 0 worksImmunology and Micro…Neuroscience: 2.40× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 10.58× its world share, 1 worksPharmacology, Toxico…Computer Science: 0.02× its world share, 0 worksComputer ScienceEngineering: 0.10× its world share, 0 worksEngineeringEnvironmental Science: 0.18× its world share, 0 worksEnvironmental ScienceMathematics: 0.10× its world share, 0 worksMathematicsHealth Professions: 0.84× its world share, 0 worksHealth ProfessionsMedicine: 2.35× its world share, 8 worksMedicineArts and Humanities: 0.42× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.30× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 1.07× its world share, 0 worksEconomics, Econometr…Psychology: 0.90× its world share, 0 worksPsychologySocial Sciences: 0.90× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 10.6×. Every wedge is a field page.

Which keywords describe research at Novo Nordisk (Finland)?

By fractional works in all years, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Cardiovascular Disease, Diabetes, Obesity, Metabolic Syndrome, Type 2 Diabetes and Heart Failure.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycemic Control7▲ 117×4 topics
  2. Insulin Therapy7▲ 145×3 topics
  3. Cardiovascular Disease6▲ 11×18 topics
  4. Diabetes5▲ 22×8 topics
  5. Obesity5▲ 15×13 topics
  6. Metabolic Syndrome5▲ 13×14 topics
  7. Type 2 Diabetes4▲ 54×3 topics
  8. Heart Failure4▲ 21×7 topics
  9. Clinical Guidelines4▲ 26×3 topics
  10. Cardiovascular Outcomes3▲ 188×1 topic
  11. Genetic Variation3▲ 25×5 topics
  12. Glucose Control3▲ 188×1 topic
  13. Insulin Resistance3▲ 17×6 topics
  14. Type 1 Diabetes3▲ 77×2 topics
  15. Inflammation3▲ 3.0×27 topics
  16. Cancer Risk2▲ 23×4 topics
  17. Complications2▲ 11×3 topics
  18. Insulin Signaling2▲ 44×2 topics
  19. Tumor Suppression2▲ 51×2 topics
  20. AMP-Activated Protein Kinase2▲ 112×1 topic
  21. Continuous Glucose Monitoring2▲ 125×1 topic
  22. Hypoglycemia2▲ 125×1 topic
  23. Metformin2▲ 137×1 topic
  24. Gene Expression2▲ 8.9×6 topics
  25. Population Genetics2▲ 32×3 topics
  26. Genome-Wide Association2▲ 60×2 topics
  27. Lifestyle Intervention2▲ 62×2 topics
  28. Public Health2▲ 3.7×7 topics
  29. Atherosclerosis2▲ 13×6 topics
  30. Diabetes Mellitus2▲ 21×3 topics
  31. Haplotype Mapping2▲ 176×1 topic
  32. Mendelian Randomization2▲ 176×1 topic
  33. Weight Loss2▲ 29×4 topics
  34. Glucose Metabolism2▲ 40×2 topics
  35. Cholesterol2▲ 20×3 topics
  36. Global Prevalence2▲ 37×1 topic
  37. Precision Medicine1▲ 10×6 topics
  38. Inflammatory Response1▲ 35×2 topics
  39. Behavior Change1▲ 24×2 topics
  40. Chronic Diseases1▲ 9.4×2 topics

Which research topics does Novo Nordisk (Finland) publish most on?

By volume in 2022–2025: Genetic Associations and Epidemiology, European and International Law Studies, Diabetes Treatment and Management and Diabetes, Cardiovascular Risks, and Lipoproteins.

Genetic Associations and…2Genetic Associations and Epidemiology: 2 fractional worksEuropean and International Law Studies: 1 fractional worksDiabetes Treatment and Management: 1 fractional worksDiabetes, Cardiovascular Risks, and Lipoproteins: 0 fractional worksEducation, Healthcare and Sociology Research: 0 fractional worksHistorical Influence and Diplomacy: 0 fractional worksLiver Disease Diagnosis and Treatment: 0 fractional worksBariatric Surgery and Outcomes: 0 fractional worksECG Monitoring and Analysis: 0 fractional worksAdipose Tissue and Metabolism: 0 fractional works
GeneticsPolitical Science and International RelationsEndocrinology, Diabetes and MetabolismSocial Psychology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Genetic Associations and Epidemiology Genetics 2 works
  2. 2 European and International Law Studies Political Science and International Relations 1 works
  3. 3 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 1 works
  4. 4 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 0 works
  5. 5 Education, Healthcare and Sociology Research Social Psychology 0 works
  6. 6 Historical Influence and Diplomacy Political Science and International Relations 0 works
  7. 7 Liver Disease Diagnosis and Treatment Epidemiology 0 works
  8. 8 Bariatric Surgery and Outcomes Surgery 0 works
  9. 9 ECG Monitoring and Analysis Cardiology and Cardiovascular Medicine 0 works
  10. 10 Adipose Tissue and Metabolism Physiology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available73.3%not open26.7%

World: 28% of research is openly available.

with international co-authors78.3%domestic only21.7%

World: 19% is written across borders.

How has Novo Nordisk (Finland)'s research output changed?

Output in 2018–2022 was 61% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Espoo

All research institutions in Espoo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.